CBLL vs BFLY vs CV Stock Comparison

Ceribell, Butterfly Network and CapsoVision Prices as of Nov 16, 2026 Peers: Industry group
CBLL Ceribell, Inc.
$26.42 +5.5% 1M +104.8% 1Y
Market cap
$999.85M
P/E
–
Revenue (TTM)
$108.72M
Div. yield
–
Diagnostic Equipment Healthcare
2 wins
BFLY Butterfly Network, Inc.
$5.71 -21.1% 1M +169.3% 1Y
Market cap
$1.54B
P/E
–
Revenue (TTM)
$123.25M
Div. yield
–
Diagnostic Equipment Healthcare
5 wins
CV CapsoVision, Inc
$6.47 -0.9% 1M +26.4% 1Y
Market cap
$334.51M
P/E
–
Revenue (TTM)
$13.92M
Div. yield
–
Diagnostic Equipment Healthcare

Head to Head

7 decided of 12

Butterfly Network leads on 5 of the 12 questions below (Butterfly Network 5, Ceribell 2). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionCBLLBFLYCVLeader
Larger companyMarket capitalisation $999.85M $1.54B $334.51M BFLY
Cheaper on earningsLower P/E, profitable companies only -13.5x -28.8x -11.4x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS — — — –
Faster revenue growthRevenue growth, trailing twelve months +31.3% +39.4% +6.4% BFLY
More profitableNet margin, trailing twelve months -68.0% -43.6% -210.1% BFLY
Better return on capitalReturn on invested capital — -30.5% — –
Less leveragedLower net debt / EBITDA 1.3x 2.3x — CBLL
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months +104.8% +169.3% +26.4% BFLY
Better 5-year returnAnnualised price return, 5 years — -8.7%/yr — –
Less volatileAnnualised volatility, 1 year 51.5% 112.4% 95.6% CBLL
Higher overall scoreMean of the five percentile scores vs peers 39/100 53/100 30/100 BFLY

Percentile Scorecard

CBLLBFLYCV

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisCBLLBFLYCV
Valuation 23 #188 of 243 31 #167 of 243 12 #213 of 243
Growth 21 #180 of 228 88 #28 of 228 6 #214 of 228
Profitability 36 #142 of 222 39 #137 of 222 20 #179 of 222
Financial Health 79 #52 of 248 68 #80 of 248 90 #27 of 248
Shareholder Returns 37 #101 of 159 41 #94 of 159 23 #122 of 159
Overall 39 53 30
  • CBLL ranked among 252 companies in Medical Devices and Diagnostics
  • BFLY ranked among 252 companies in Medical Devices and Diagnostics
  • CV ranked among 252 companies in Medical Devices and Diagnostics

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodCBLLBFLYCVSPY
1 month +5.5%-21.1%-0.9% -3.0%
3 months +8.3%-36.7%+0.3% -4.2%
6 months +59.3%+48.7%+1.7% +0.2%
Year to date +20.5%+50.3%-39.5% +8.5%
1 year +104.8%+169.3%+26.4% +10.1%
3 years —+388.0%— +64.1%
3 years, per year —+69.7%— +18.0%
5 years —-36.6%— +58.1%
5 years, per year —-8.7%— +9.6%

Risk

MeasureCBLLBFLYCVSPY
Volatility, 1Y 51.5%112.4%95.6% 13.8%
Downside volatility, 1Y 50.0%93.7%88.8% 14.2%
Beta vs S&P 500, 1Y 1.132.980.71 1.00
Return / volatility, 1Y 2.041.510.28 0.74
Max drawdown, 5Y -63.9%-92.2%-67.8% -25.4%
From 52-week high -6.5%-42.6%-55.1% -5.0%
52-week high $28.27$9.94$14.42 $779.14
52-week low $12.89$1.97$4.64 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleCBLLBFLYCV
P/E now vs peer median -13.6xmedian 26.5x -30.2xmedian 26.5x -10.4xmedian 26.5x
P/S now vs peer median 9.3xmedian 2.7x 13.2xmedian 2.7x 23.2xmedian 2.7x
EV/EBITDA now vs peer median -12.3xmedian 18.6x -29.5xmedian 18.6x -10.3xmedian 18.6x
P/FCF now vs peer median -18.0xmedian 25.6x -58.9xmedian 25.6x -11.0xmedian 25.6x
P/B now vs peer median 8.6xmedian 2.5x 8.8xmedian 2.5x 12.3xmedian 2.5x
PEG now vs peer median —median 0.98 -1.00median 0.98 —median 0.98

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsCBLLBFLYCV
Revenue $108.72M $123.25M $13.92M
Gross profit $97.04M $86.60M $6.92M
Operating income -$75.87M -$57.83M -$29.52M
Net income -$73.88M -$53.69M -$29.25M
Free cash flow -$56.43M -$27.55M -$29.28M
R&D $25.37M $39.57M $20.27M
EPS (diluted) $-1.92 $-0.20 $-0.58
Cash & equivalents $41.99M $122.30M $21.76M
Total debt $21.22M $2.92M –
Shares (diluted) 38.50M 266.50M 50.57M
Enterprise value $452.67M $1.01B $275.63M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricCBLLBFLYCV
P/E -13.6x -30.2x -10.4x
P/FCF -18.0x -58.9x -11.0x
P/Operating cash flow -18.1x -69.4x -11.1x
P/S 9.3x 13.2x 23.2x
P/B 8.6x 8.8x 12.3x
P/Tangible book 8.6x 9.1x 12.3x
EV/EBITDA -12.3x -29.5x -10.3x
EV/EBIT -12.1x -26.0x -10.2x
EV/Revenue 8.4x 12.2x 21.6x
EV/FCF -16.3x -54.6x -10.3x
EV/Operating cash flow -16.4x -64.3x -10.3x
PEG (3Y EPS CAGR) – -1.00 –

Growth

14 metrics
MetricCBLLBFLYCV
Revenue growth (1Y) 31.3% 39.4% 6.4%
Revenue CAGR (3Y) – 21.7% –
Gross profit growth (1Y) 33.2% 126.4% -0.5%
Gross profit CAGR (3Y) – 30.5% –
Operating income growth (1Y) -33.8% 33.5% -30.1%
Operating income CAGR (3Y) – 26.9% –
Net income growth (1Y) -40.8% 32.8% -29.6%
Net income CAGR (3Y) – 24.2% –
EPS growth (1Y) -34.6% 36.4% -18.5%
EPS CAGR (3Y) – 30.4% –
Operating cash flow growth (1Y) -40.0% 5.8% -41.9%
Operating cash flow CAGR (3Y) – 41.1% –
Free cash flow growth (1Y) -37.8% -0.1% -41.7%
Free cash flow CAGR (3Y) – 38.8% –

Profitability

14 metrics
MetricCBLLBFLYCV
Gross margin 89.3% 70.3% 49.7%
EBITDA margin -68.4% -41.4% -210.4%
Operating margin -69.8% -46.9% -212.1%
Pretax margin -68.0% -43.5% -209.9%
Net margin -68.0% -43.6% -210.1%
FCF margin -51.9% -22.4% -210.3%
Operating cash flow margin -51.5% -19.0% -209.7%
Return on equity -60.3% -28.7% -148.0%
Return on assets -46.0% -18.8% -114.0%
Return on invested capital – -30.5% –
Return on capital employed -52.9% -26.6% -151.1%
Asset turnover 0.7x 0.4x 0.5x
Cash conversion (OCF / net income) 0.8x 0.4x 1.0x
Stock comp / revenue 18.6% 20.8% 14.8%

Financial Health

11 metrics
MetricCBLLBFLYCV
Debt / assets 13.6% 1.0% –
Debt / equity 0.2x 0.0x –
Net debt / EBITDA 1.3x 2.3x –
Debt / FCF -0.4x -0.1x –
Liabilities / assets 24.8% 36.0% 19.5%
Equity / assets 75.2% 64.0% 80.5%
Interest coverage -47.4x -46.8x –
Current ratio 8.2x 3.6x 5.1x
Quick ratio 7.6x 2.3x 4.0x
Cash ratio 6.5x 1.8x 3.6x
Altman Z-score 13.25 5.44 21.14

Shareholder Returns

7 metrics
MetricCBLLBFLYCV
Dividend yield – – –
Net buyback yield -0.8% -0.5% -4.4%
Shareholder yield -0.8% -0.5% -4.4%
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusCBLLBFLYCV
EPS, next fiscal year $-1.96FY2026 $-0.06FY2026 $-0.58FY2026
Revenue, next fiscal year $118.62MFY2026 $117.62MFY2026 $13.82MFY2026
Revenue growth, next FY +33.2%FY2026 +20.5%FY2026 +2.0%FY2026
Revenue growth, the year after +21.3% +22.7% +47.0%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersCBLLBFLYCV
Held by institutions 79.9% 58.4% 10.2%
Institutions holding 124 248 50
Change in shares held, QoQ +2.2% +13.9% +27.6%
Institutions buying 74 144 36
Institutions selling 36 59 8
Buyers to sellers 2.06 2.44 4.50

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

CBLLBFLYCV
CBLL 1.00 0.39 0.09
BFLY 0.39 1.00 0.07
CV 0.09 0.07 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, CBLL, BFLY and CV?

Butterfly Network (BFLY) is the largest by market capitalisation: Ceribell (CBLL) $999.85M, Butterfly Network (BFLY) $1.54B, CapsoVision (CV) $334.51M.

Which company is growing faster?

Butterfly Network (BFLY) grew revenue fastest over the trailing twelve months: Ceribell (CBLL) +31.3%, Butterfly Network (BFLY) +39.4%, CapsoVision (CV) +6.4%.

Which company is more profitable?

Butterfly Network (BFLY) has the highest net margin (Ceribell (CBLL) -68.0%, Butterfly Network (BFLY) -43.6%, CapsoVision (CV) -210.1%).

Which stock has performed better?

Over the past year Butterfly Network (BFLY) returned the most: Ceribell (CBLL) +104.8%, Butterfly Network (BFLY) +169.3%, CapsoVision (CV) +26.4%. Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Ceribell (CBLL) has been the steadiest (Ceribell (CBLL) 51.5%, Butterfly Network (BFLY) 112.4%, CapsoVision (CV) 95.6%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, CBLL, BFLY and CV?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Butterfly Network (BFLY) leads on 5. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.